Regeneron at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Regeneron takes part in 3 sessions at Antibody Engineering 2026 in San Diego. Its program spans dose selection for new biologics, antibodies against hard-to-reach targets such as IgE responses, and antibodies that bind three or more targets. The dose work follows a molecule from its design through to an approved treatment regimen.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Regeneron Tarrytown, NY | |
Biotechnology company that discovers, develops and markets antibody medicines, including bispecific antibodies, using its VelocImmune mouse platform. | Talk Sun Dec 13 3:45pm–4:15pm From Molecule Design to Approved Regimens: A Clinical Pharmacology Perspective on Dose Selection for Next-Generation Biologics How measurements of drug levels and effects in the body guide the first human dose and the final approved dosing schedule. Talk Mon Dec 14 5:15pm–5:45pm Targeting IgE Responses Beyond oncology Talk Wed Dec 16 8:10am–8:15am |
Instantly find 20 buyers from Regeneron
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect, The Antibody Society or Antibody Engineering & Therapeutics. Submit a correction